Clinical Trial Update: A 14 Week, Randomized, Placebo-Controlled Cross-Over Study of Methylphenidate Hydrochloride Controlled Release Capsules in Adult ADHD With and Without Anxiety Disorder Comorbidity [Phase 4]

View source ↗

Summary

A Phase 4 randomized, placebo-controlled crossover trial evaluated methylphenidate hydrochloride controlled release capsules in adults with ADHD, with and witho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Generalized Anxiety Disorder

Drugs mentioned

• Methylphenidate Hydrochloride Controlled Release Capsules (methylphenidate hydrochloride controlled release)

Snippet

Sponsor: McMaster University | Conditions: Attention Deficit Hyperactivity Disorder, Generalized Anxiety Disorder | Phase 4 | Status: COMPLETED